Thrombosis et diathesis haemorrhagica, 0340-6245

Journal

More filtering options
  1. 2020
  2. Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis

    Pratima Chowdary, Kathelijn Fischer, Peter W. Collins, Amy Cotterill, Barbara A. Konkle, Victor Blanchette, Steven W. Pipe, Erik Berntorp, Martin Wolfsegger, Werner Engl & Gerald Spotts, 2020 May 5, In : Thrombosis and Haemostasis. 120, 5, p. 728-736 9 p.

    Research output: Contribution to journalArticle

  3. Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology

    Behnood Bikdeli, Thomas McAndrew, Aaron Crowley, Shmuel Chen, Ghazaleh Mehdipoor, Björn Redfors, Yangbo Liu, Zixuan Zhang, Mengdan Liu, Yiran Zhang, Dominic P. Francese, David Erlinge, Stefan K. James, Yaling Han, Yi Li, Adnan Kastrati, Stefanie Schüpke, Rod H. Stables, Adeel Shahzad, Philippe Gabriel Steg & 5 others, Patrick Goldstein, Enrico Frigoli, Roxana Mehran, Marco Valgimigli & Gregg W. Stone, 2020 Feb, In : Thrombosis and Haemostasis. 120, 2, p. 348-362 15 p.

    Research output: Contribution to journalLetter

  4. 2019
  5. Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study

    Giuseppe Patti, Giuseppe Di Martino, Fabrizio Ricci, Giulia Renda, Sabina Gallina, Viktor Hamrefors, Olle Melander, Richard Sutton, Gunnar Engström, Raffaele De Caterina & Artur Fedorowski, 2019 Nov, In : Thrombosis and Haemostasis. 119, 11, p. 1773-1784

    Research output: Contribution to journalArticle

  6. Next-Generation Sequencing of 17 Genes Associated with Venous Thromboembolism Reveals a Deficit of Non-Synonymous Variants in Procoagulant Genes

    Eric Manderstedt, Christina Lind-Halldén, Peter Svensson, Bengt Zöller & Christer Halldén, 2019, In : Thrombosis and Haemostasis. 119, 09, p. 1441-1450

    Research output: Contribution to journalArticle

  7. The Ultimate Murine Model of Immune Thrombocytopaenia

    John W. Semple & Rick Kapur, 2019, In : Thrombosis and Haemostasis. 119, 3, p. 353-354 2 p.

    Research output: Contribution to journalDebate/Note/Editorial

  8. 2018
  9. Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients

    Christina Lind-Halldén, Eric Manderstedt, Daniel Carlberg, Stefan Lethagen & Christer Halldén, 2018 Jul 4, In : Thrombosis and Haemostasis.

    Research output: Contribution to journalArticle

  10. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

    Tara M. Stanne, Maja Olsson, Erik Lorentzen, Annie Pedersen, Anders Gummesson, Ann Gils, Katarina Jood, Gunnar Engström, Olle Melander, Paul J. Declerck & Christina Jern, 2018, In : Thrombosis and Haemostasis. 118, 2, p. 298-308

    Research output: Contribution to journalArticle

  11. 2017
  12. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

    Maria Elisa Mancuso, Kathelijn Fischer, Elena Santagostino, Johannes Oldenburg, Helen Platokouki, Carmen Escuriola-Ettingshausen, George E Rivard, Ana Rosa Cid, Manuel Carcao, Rolf Ljung, Pia Petrini, Carmen Altisent, Gili Kenet, Karin Kurnik, Günther Auerswald, Hérvè Chambost, Anne Mäkipernaa, Angelo Claudio Molinari, Mike Williams, H Marijke van den Berg & 1 others, European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group, 2017 Dec, In : Thrombosis and Haemostasis. 117, 12, p. 2274-2282

    Research output: Contribution to journalArticle

  13. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR

    Per Sandén, Henrik Renlund, Peter J. Svensson & Anders Själander, 2017 Jan 1, In : Thrombosis and Haemostasis. 117, 1, p. 27-32 6 p.

    Research output: Contribution to journalArticle

  14. Extracellular nucleic acids in immunity and cardiovascular responses: Between alert and disease

    Klaus T. Preissner & Heiko Herwald, 2017, In : Thrombosis and Haemostasis. 117, 7, p. 1272-1282 11 p.

    Research output: Contribution to journalReview article

  15. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

    Susanna Lallukka, Panu K. Luukkonen, You Zhou, Elina Isokuortti, Marja Leivonen, Anne Juuti, Antti Hakkarainen, Marju Orho-Melander, Nina Lundbom, Vesa M. Olkkonen, Riitta Lassila & Hannele Yki-Järvinen, 2017, In : Thrombosis and Haemostasis. 117, 2, p. 286-294 9 p.

    Research output: Contribution to journalArticle

  16. Paracelsus, poison, and colistin

    Heiko Herwald, 2017, In : Thrombosis and Haemostasis. 117, 9, p. 1661 1 p.

    Research output: Contribution to journalDebate/Note/Editorial

  17. The importance of genetic factors for the development of arthropathy: A longitudinal study of children and adolescents with haemophilia A

    Edward D Gomperts, John Schwarz, Sharyne M. Donfield, Alice E. Lail, Jan Astermark, W. Keith Hoots, Cheryl A. Winkler & Erik Berntorp, 2017, In : Thrombosis and Haemostasis. 117, 2, p. 277-285 9 p.

    Research output: Contribution to journalArticle

  18. 2016
  19. Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis

    Xiao Wang, Kristina Sundquist, Johan L. Elf, Karin Strandberg, Peter J. Svensson, Anna Hedelius, Karolina Palmér, Ashfaque A. Memon, Jan Sundquist & Bengt Zöller, 2016 Aug 1, In : Thrombosis and Haemostasis. 116, 2, p. 328-336 9 p.

    Research output: Contribution to journalArticle

  20. Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors

    H. Marijke van den Berg, S. Mojtaba Hashemi, Kathelijn Fischer, Pia Petrini, Rolf Ljung, Anne Rafowicz, Manuel Carcao, Günter Auerswald, Karin Kurnik, Gili Kenet & Elena Santagostino, 2016 Apr 1, In : Thrombosis and Haemostasis. 115, 4, p. 729-737 9 p.

    Research output: Contribution to journalArticle

  21. BRCA2 gene mutations and coagulation-associated biomarkers

    Pedro Perez-Segura, José J. Zamorano-León, Daniel Acosta, Juana María Santos-Sancho, Javier Modrego, Trinidad Caldés, Miguel De La Hoya, Eduardo Díaz-Rubio, Isabel Díaz-Millán, Natalia De Las Heras, Luis Alfonso Rico Zalba, Vicente Lahera, Olle Melander & Antonio López Farré, 2016, In : Thrombosis and Haemostasis. 115, 2, p. 415-423 9 p.

    Research output: Contribution to journalArticle

  22. Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.

    Rolf Ljung, Kathelijn Fischer, Manuel Carcao, Elena Santagostino, Marilyn J Manco-Johnson & Prasad Mathew, 2016, In : Thrombosis and Haemostasis. 115, 5, p. 913-920

    Research output: Contribution to journalReview article

  23. 2015
  24. Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.

    Clément Naudin, Sinead Hurley, Erik Malmström, T Plug, Oonagh Shannon, J C M Meijers, Matthias Mörgelin, Lars Björck & Heiko Herwald, 2015, In : Thrombosis and Haemostasis. 114, 4, p. 717-726

    Research output: Contribution to journalArticle

  25. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

    Sofia Somajo, Josefin Ahnström, J Fernandez-Recio, M Gierula, B O Villoutreix & Björn Dahlbäck, 2015, In : Thrombosis and Haemostasis. 113, 5, p. 976-987

    Research output: Contribution to journalArticle

  26. Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.

    S Kohler, T Hallström, Birendra Singh, Kristian Riesbeck, G Sparta, P F Zipfel & S Hammerschmidt, 2015, In : Thrombosis and Haemostasis. 113, 1, p. 125-142

    Research output: Contribution to journalArticle

  27. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

    Asa C. Strom, Amanda J. Cross, Jennifer E. Cole, Paul A. Blair, Christoph Leib, Michael E. Goddard, Elizabeth C. Rosser, Inhye Park, Anna Hultgardh Nilsson, Jan Nilsson, Claudia Mauri & Claudia Monaco, 2015, In : Thrombosis and Haemostasis. 114, 4, p. 835-847

    Research output: Contribution to journalArticle

  28. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

    Gerhard Dickneite, Heiko Herwald, Wolfgang Korte, Yannick Allanore, Christopher P. Denton & Marco Matucci Cerinic, 2015, In : Thrombosis and Haemostasis. 113, 4, p. 686-697

    Research output: Contribution to journalReview article

  29. Genetic aspects of thrombotic disease

    Pablo Garcia de Frutos & Bengt Zöller, 2015, In : Thrombosis and Haemostasis. 114, 5, p. 883-884

    Research output: Contribution to journalDebate/Note/Editorial

  30. Safety and efficacy of well managed warfarin: A report from the Swedish quality register Auricula

    Vilhelm Sjogren, Bartosz Grzymala-Lubanski, Henrik Renlund, Leif Friberg, Gregory Y. H. Lip, Peter Svensson & Anders Sjalander, 2015, In : Thrombosis and Haemostasis. 113, 6, p. 1370-1377

    Research output: Contribution to journalArticle

  31. 2014
  32. Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

    David Erlinge, S James, S Duvvuru, J A Jakubowski, Henrik Wagner, C Varenhorst, U S Tantry, P B Brown, D Small, B A Moser, S Sundseth, J R Walker, K J Winters & P A Gurbel, 2014, In : Thrombosis and Haemostasis. 111, 5, p. 943-950

    Research output: Contribution to journalArticle

  33. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories

    Cristina Solomon, Ekaterina Baryshnikova, Armando Tripodi, Christoph J. Schlimp, Herbert Schoechl, Janne Cadamuro, Dag Winstedt, Lars Asmis & Marco Ranucci, 2014, In : Thrombosis and Haemostasis. 112, 1, p. 109-117

    Research output: Contribution to journalArticle

  34. Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome

    Xavier Blanchet, Katja Cesarek, Johanna Brandt, Heiko Herwald, Daniel Teupser, Helmut Kuechenhoff, Ela Karshovska, Sebastian F. Mause, Wolfgang Siess, Hermann Wasmuth, Oliver Soehnlein, Rory R. Koenen, Christian Weber & Philipp von Hundelshausen, 2014, In : Thrombosis and Haemostasis. 112, 6, p. 1277-1287

    Research output: Contribution to journalArticle

  35. Targeted mass spectrometry analysis of neutrophil-derived proteins released during sepsis progression.

    Erik Malmström, A Davidova, Matthias Mörgelin, Adam Linder, M Larsen, K Qvortrup, Pontus Nordenfelt, Oonagh Shannon, O Dzupova, M Holub, Johan Malmström & Heiko Herwald, 2014, In : Thrombosis and Haemostasis. 112, 6, p. 1230-1243

    Research output: Contribution to journalArticle

  36. The coagulation system and its function in early immune defense.

    T van der Poll & Heiko Herwald, 2014, In : Thrombosis and Haemostasis. 112, 4, p. 640-648

    Research output: Contribution to journalArticle

  37. The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

    Paul A. Gurbel, Thomas O. Bergmeijer, Udaya S. Tantry, Jurrien M. ten Berg, Dominick J. Angiolillo, Stefan James, Tomas L. Lindahl, Peter Svensson, Joseph A. Jakubowski, Patricia B. Brown, Suman Duvvuru, Scott Sundseth, Joseph R. Walker, David Small, Brian A. Moser, Kenneth J. Winters & David Erlinge, 2014, In : Thrombosis and Haemostasis. 112, 3, p. 589-597

    Research output: Contribution to journalArticle

  38. 2013
  39. Anti-inflammatory, anti-coagulant, anti-biotic?

    Heiko Herwald, 2013, In : Thrombosis and Haemostasis. 109, 4, p. 582-582

    Research output: Contribution to journalDebate/Note/Editorial

  40. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides - a novel link between coagulation and innate immunity.

    Lisa Påhlman, Matthias Mörgelin, Gopinath Kasetty, Anders Olin, Artur Schmidtchen & Heiko Herwald, 2013, In : Thrombosis and Haemostasis. 109, 5, p. 930-939

    Research output: Contribution to journalArticle

  41. Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.

    Oscar Braun, D J Angiolillo, J L Ferreiro, J A Jakubowski, K J Winters, M B Effron, S Duvvuru, T M Costigan, S Sundseth, J R Walker, J F Saucedo, N S Kleiman & C Varenhorst, 2013, In : Thrombosis and Haemostasis. 110, 6, p. 1223-1231

    Research output: Contribution to journalArticle

  42. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation

    Sara Calzavarini, Bruno O. Villoutreix, Barbara Lunghi, Ruzica Livaja Koshiar, Francesco Bernardi & Björn Dahlbäck, 2013, In : Thrombosis and Haemostasis. 110, 1, p. 31-38

    Research output: Contribution to journalArticle

  43. Old genes and new genes: The evolution of the kallikrein locus.

    Åke Lundwall, 2013, In : Thrombosis and Haemostasis. 109, 6

    Research output: Contribution to journalReview article

  44. 2012
  45. Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems

    Prosenjit Sen, Curtis A. Clark, Ramakrishnan Gopalakrishnan, Ulla Hedner, Charles T. Esmon, Usha R. Pendurthi & L. Vijaya Mohan Rao, 2012, In : Thrombosis and Haemostasis. 107, 5, p. 951-961

    Research output: Contribution to journalArticle

  46. Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.

    Carl Högberg, Olof Gidlöf, F Deflorian, K A Jacobson, A Abdelrahman, C E Müller, Björn Olde & David Erlinge, 2012, In : Thrombosis and Haemostasis. 108, 1, p. 119-132

    Research output: Contribution to journalArticle

  47. Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor

    Alexander G. G. Turpie, Reinhold Kreutz, Juan Llau, Bo Norrving & Sylvia Haas, 2012, In : Thrombosis and Haemostasis. 108, 5, p. 876-886

    Research output: Contribution to journalArticle

  48. Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency

    Christina Lind-Hallden, Anna Dahlen, Andreas Hillarp, Bengt Zöller, Björn Dahlbäck & Christer Hallden, 2012, In : Thrombosis and Haemostasis. 108, 1, p. 94-100

    Research output: Contribution to journalArticle

  49. Translational platelet research in patients with coronary artery disease: hat are the rnalor knowledge gaps?

    Paul A. Gurbel, Matthew T. Roe, Joseph A. Jakubowski, Svathi Shah, David Erlinge, Shaun G. Goodman, Kurt Huber, Mark Y. Chan, Jan H. Cornel, Udaya S. Tantry & E. Magnus Ohman, 2012, In : Thrombosis and Haemostasis. 108, 1, p. 12-20

    Research output: Contribution to journalReview article

  50. 2011
  51. A large deletion identified in a Swedish family with type 1 VWD

    Anna M. Johansson, Elsa Lanke, Torbjörn Säll, Stefan Lethagen & Christer Halldén, 2011, In : Thrombosis and Haemostasis. 105, 4, p. 733-734

    Research output: Contribution to journalLetter

  52. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Mercedes Valls Seron, Tom Plug, J. Arnoud Marquart, Pauline F. Marx, Heiko Herwald, Philip G. de Groot & Joost C. M. Meijers, 2011, In : Thrombosis and Haemostasis. 106, 4, p. 609-616

    Research output: Contribution to journalArticle

Previous 1 2 3 Next